Abstract
Comparison of Tumor Lysis Syndrome (TLS) Risk Reduction and Incidence in Different Venetoclax-Based Combinations within the Randomized Phase 3 GAIA (CLL13) Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have